In contrast, in most solid tumors, both NR4A1 and NR4A2 exhibit pro-oncogenic activity, whereas, in limited studies, NR4A3 exhibits either minimal activity [23] or acts as a tumor suppressor [39]. This evidence concerns the gene NR4A3 and neoplasm.